You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adamantinoma

Showing 1 - 25 of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Craniopharyngioma, Child, Craniopharyngioma, Recurrent Craniopharyngioma Trial in San Francisco (Nivolumab, DAY101)

Not yet recruiting
  • Craniopharyngioma, Child
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jul 15, 2022

Craniopharyngioma Trial in Paris, Villejuif (Protontherapy)

Completed
  • Craniopharyngioma
  • Protontherapy
  • Paris, France
  • +2 more
Apr 21, 2022

Osteofibrous Dysplasia (Kempson-Campanacci's Disease)

Active, not recruiting
  • Osteofibrous Dysplasia
  • study of osteofibrous dysplasia features
  • Bologna, Italy
    Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli
Aug 9, 2021

Craniopharyngioma With Tumoral Hemorrhage

Completed
  • Craniopharyngioma
  • Apoplexy
  • intratumoral hemorrhage
  • (no location specified)
Jun 21, 2021

Craniopharyngioma, Obesity Trial in Oldenburg

Recruiting
  • Craniopharyngioma
  • Obesity
    • Oldenburg, Niedersachsen, Germany
      Klinikum Oldenburg
    Mar 29, 2022

    Astrocytoma, Ependymoma, Ganglioglioma Trial in Maastricht, Delft, Groningen (ProTRAIT)

    Recruiting
    • Astrocytoma
    • +11 more
    • ProTRAIT
    • Maastricht, Limburg, Netherlands
    • +2 more
    Apr 12, 2022

    Craniopharyngioma Trial in Jacksonville, Memphis (procedure, device, drug)

    Active, not recruiting
    • Craniopharyngioma
    • Radical Surgery or Limited Surgery
    • +3 more
    • Jacksonville, Florida
    • +1 more
    Jan 5, 2022

    Craniopharyngioma Trial in Memphis (Proton Therapy, Surgery)

    Recruiting
    • Craniopharyngioma
    • Proton Therapy
    • Surgery
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Aug 20, 2021

    Craniopharyngioma, Hypothalamic Obesity Trial in Philadelphia (Syntocinon, Placebo (for Syntocinon))

    Active, not recruiting
    • Craniopharyngioma
    • Hypothalamic Obesity
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Jun 2, 2021

    Long-Term Longitudinal QoL in Patients Undergoing EEA

    Recruiting
    • Pituitary Tumor
    • +7 more
      • Columbus, Ohio
        Ohio State University
      Jun 20, 2021

      Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Binimetinib Oral Tablet

      Not yet recruiting
      • Adamantinous Craniopharyngioma
      • Recurrent Adamantinomatous Craniopharyngioma
      • Binimetinib Oral Tablet [Mektovi]
      • Aurora, Colorado
      • +17 more
      Nov 28, 2022

      Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Tocilizumab)

      Recruiting
      • Adamantinomatous Craniopharyngioma
      • Recurrent Adamantinomatous Craniopharyngioma
      • Aurora, Colorado
      • +17 more
      Jan 8, 2023

      Craniopharyngioma, Hypothalamic Obesity, Metabolic Syndrome Trial in Vancouver (Hypothalamic Deep Brain Stimulation)

      Withdrawn
      • Craniopharyngioma
      • +2 more
      • Hypothalamic Deep Brain Stimulation
      • Vancouver, British Columbia, Canada
        Leslie and Gordon Diamond Health Center
      Oct 29, 2020

      Ameloblastoma, BRAF Gene Mutation Trial in Stanford (Dabrafenib, Trametinib)

      Completed
      Has Results
      • Ameloblastoma
      • BRAF Gene Mutation
      • Stanford, California
        Stanford University, School of Medicine
      Jan 17, 2020

      Childhood Craniopharyngioma Trial in United States (peginterferon alfa-2b, laboratory biomarker analysis)

      Terminated
      Has Results
      • Childhood Craniopharyngioma
      • peginterferon alfa-2b
      • laboratory biomarker analysis
      • Los Angeles, California
      • +8 more
      Feb 20, 2020

      Examination of Sleep and Family Functioning in Pediatric

      Completed
      • Craniopharyngioma
        • Memphis, Tennessee
          St . Jude Children's Research Hospital
        Mar 7, 2019

        Craniopharyngiomas, Hypothalamic Obesity Trial in France (Exenatide, Placebo)

        Completed
        • Craniopharyngiomas
        • Hypothalamic Obesity
        • Angers, France
        • +10 more
        Oct 11, 2018

        Hypothalamic Obesity Trial in Toronto (Diazoxide, Metformin)

        Completed
        • Hypothalamic Obesity
        • Toronto, Ontario, Canada
          The Hospital for Sick Children
        Nov 13, 2017

        Obesity, Overweight, Craniopharyngioma Trial in Nashville (Exenatide)

        Completed
        Has Results
        • Obesity
        • +2 more
        • Nashville, Tennessee
          Vanderbilt University
        Jan 17, 2017

        Sleep Wake and Melatonin Pattern in Craniopharyngioma

        Completed
        • Sleep Disorders, Circadian Rhythm
        • Craniopharyngioma
          • (no location specified)
          Feb 21, 2017

          Acoustic Schwannoma, Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma Trial in Iowa City (radiation, procedure, other)

          Withdrawn
          • Acoustic Schwannoma
          • +94 more
          • gallium Ga 68-edotreotide
          • +3 more
          • Iowa City, Iowa
            University of Iowa Hospitals and Clinics
          Apr 27, 2017

          Obesity, Over-weight, Hypothalamic Injury Trial in Australia, United States (ZGN-440 sterile diluent, ZGN-440 for injectable

          Completed
          • Obesity
          • +3 more
          • ZGN-440 sterile diluent
          • ZGN-440 for injectable suspension
          • St. Paul, Minnesota
          • +3 more
          Jul 14, 2016

          Acoustic Schwannoma, Adult Anaplastic (Malignant) Meningioma, Adult Anaplastic Astrocytoma Trial in New York, Charlottesville

          Completed
          • Acoustic Schwannoma
          • +28 more
          • 3-Dimensional Conformal Radiation Therapy
          • +6 more
          • New York, New York
          • +1 more
          Sep 28, 2015

          Pituitary Tumors, Craniopharyngiomas Trial in Chengdu (Hydrocortisone, Prednisone)

          Unknown status
          • Pituitary Neoplasms
          • Craniopharyngiomas
          • Chengdu, Sichuan, China
            West China Hospital, Sichuan University
          Jul 11, 2014

          Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood CNS Choriocarcinoma, Childhood CNS Germinoma Trial in Canada, United

          Terminated
          • Childhood Atypical Teratoid/Rhabdoid Tumor
          • +45 more
          • gamma-secretase/Notch signalling pathway inhibitor RO4929097
          • +3 more
          • Palo Alto, California
          • +11 more
          Nov 4, 2014